Public Profile

China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc., commonly referred to as SXT Pharmaceuticals, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in 2005, the company has established itself as a leader in the development and production of traditional Chinese medicine and modern pharmaceutical products, catering to both domestic and international markets. SXT Pharmaceuticals focuses on innovative herbal formulations and high-quality over-the-counter medications, setting itself apart with a commitment to research and development. The company has achieved significant milestones, including expanding its operational reach across Asia and beyond, while maintaining a strong market position through its unique product offerings. With a dedication to enhancing health and wellness, SXT Pharmaceuticals continues to make strides in the evolving landscape of the pharmaceutical sector.

DitchCarbon Score

How does China SXT Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

China SXT Pharmaceuticals, Inc.'s score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.

75%

China SXT Pharmaceuticals, Inc.'s reported carbon emissions

China SXT Pharmaceuticals, Inc., headquartered in CN, currently does not have available carbon emissions data, as no specific figures have been reported. Additionally, the company has not outlined any formal reduction targets or climate pledges. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and reducing their carbon footprints. This trend often includes commitments to improve energy efficiency, transition to renewable energy sources, and engage in sustainable practices throughout their supply chains. As the industry evolves, it is anticipated that China SXT Pharmaceuticals will align with these broader climate commitments in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. China SXT Pharmaceuticals, Inc.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. China SXT Pharmaceuticals, Inc. is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

China SXT Pharmaceuticals, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Kangmei Pharmaceutical Co., Ltd.

CN
Chemicals nec
Updated 4 days ago

China Traditional Chinese Medicine Holdings Co

CN
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Xiangxue Pharmaceutical Co.,Ltd.

CN
Chemicals nec
Updated 4 days ago

Beijing Tongrentang Co., Ltd

CN
Chemicals nec
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers